Valuation: Abbott Laboratories

Market Cap 172B 150B 139B 128B 242B 16,588B 246B 1,660B 652B 8,100B 646B 632B 27,966B P/E 2026 *
26.1x
P/E 2027 * 21.4x
Enterprise Value 195B 170B 157B 144B 273B 18,764B 278B 1,877B 737B 9,163B 731B 715B 31,634B EV / Sales 2026 *
3.87x
EV / Sales 2027 * 3.4x
Free-Float
86.73%
Yield 2026 *
2.58%
Yield 2027 * 2.75%
1 day+0.25%
1 week+4.69%
Current month+8.92%
1 month+9.06%
3 months+3.52%
6 months-18.83%
Current year-21.12%
1 week 87.64
Extreme 87.64
101.87
1 month 87.21
Extreme 87.21
101.87
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Director

416 0.0000%
6/30/26 Free

Director

347 0.0000%
6/30/26 Free

Director

432 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+10.71%+4.69%-24.98%-8.43% 172B
+3.84%+1.42%-6.93%-4.67% 107B
+3.85%+1.83%+3.41%+60.90% 59.92B
+3.26%+6.02%-10.29%-38.34% 44.07B
+4.23%+0.64% - - 34.76B
+7.22%+6.79%-7.31%-43.21% 30.09B
+0.96%+1.34%+61.53%-5.89% 25.61B
+0.69%+2.95%-2.18%-17.63% 20.86B
+4.57%+2.38%-2.85%-3.47% 21.55B
+2.74%+3.59%-7.34%+3.09% 20.04B
Average +2.79%+2.85%+0.34%-6.41% 53.6B
Weighted average by Cap. +1.84%+3.21%-8.36%-3.64%

Financials

2026 *2027 *
Net sales 50.33B 44B 40.69B 37.34B 70.66B 4,850B 71.89B 485B 191B 2,368B 189B 185B 8,177B 54.67B 47.78B 44.19B 40.55B 76.75B 5,268B 78.08B 527B 207B 2,572B 205B 201B 8,881B
Net income 6.84B 5.97B 5.53B 5.07B 9.6B 659B 9.76B 65.89B 25.88B 322B 25.67B 25.1B 1,110B 8.1B 7.08B 6.55B 6.01B 11.37B 780B 11.57B 78.06B 30.66B 381B 30.41B 29.74B 1,315B
Net Debt 22.58B 19.74B 18.25B 16.75B 31.7B 2,176B 32.25B 218B 85.52B 1,063B 84.8B 82.94B 3,669B 13.59B 11.88B 10.99B 10.08B 19.08B 1,309B 19.41B 131B 51.47B 639B 51.03B 49.91B 2,208B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-07-16 $98.83 +10.71% 32,755,801
26-07-15 $89.27 +0.35% 16,415,340
26-07-14 $88.96 -3.42% 12,473,875
26-07-13 $92.11 -1.94% 11,756,235
26-07-10 $93.93 -0.50% 6,913,069
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
98.83USD
Average target price
118.33USD
Spread / Average Target
+19.73%

Quarterly revenue - Rate of surprise